T R A N S F O R M A T I V E   P O S S I B I L I T I E S

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 HEALTHCARE RESEARCH AND ANALYTICS

using discipline, human imagination and innovation to overcome healthcare challenges

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INNOVATION

 

DRIVEN BY THE PURSUIT OF IMPROVEMENT

We are inspired by the advancements of pharmaceuticals, biotech companies, healthcare systems and others in the healthcare arena, and we are on a mission to turn ideas into action. We aim to push the boundaries of healthcare research to transform the standards and deliver operational excellence through innovative collaborations and cutting edge science based methodologies.  Everything we do is driven by this focus, motivates us, and reminds us of why we exist as a company.

 

 

 

 

 

 

 

THERAPEUTIC EXPERTISE

from biologics to medical devices to oncology, covering the full spectrum of healthcare today

breakthrough research for the most complex questions

 

 

 

 

 

 

MEDICAL TECHNOLOGY

Surgery using sonic beam technology

Histotripsy is the delivery of acoustic energy using high intensity sonic beam pulses via focused ultrasound, causing ablation by controlling micro bubbles.  This new technique could revolutionize select surgeries – as it provides a non-invasive means of cutting without any external incision.

The new technology can possibly be used to reduce tumors in many types of cancers, reduce fibroids, and make incisions inside the body via ultrasound while the operator views results in real-time.

ONCOLOGY

Non-invasive liquid biopsies in oncology

The use of liquid biopsies in oncology care has provided a real break-through by introducing a non-invasive detector and monitor for tumors and mutations that measures circulating epithelial cells (tumor cells) in whole blood. This technology is used for enumeration and phenotyping in patients with metastatic breast, colorectal or prostate cancer, but the wider use of this technique is potentially on the way.

This technology has current formal approval for use in the U.S. and China, and is being used worldwide.

ALZHEIMER’S

New clues in the genetics of Alzheimer’s disease 

Similar to other major diseases which plague humanity, Alzheimer’s disease (AD) is a complex disease with multifactorial underlying potential causes, but scientists studying the connection between genetic markers and Alzheimer’s disease (AD) recently found 75 independent potential factors, including 42 brand new signals which were not previously known to be connected.

The future may provide the development of gene-specific treatments and personalized medicine to avoid the development of AD.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A COMMITMENT TO EXCELLENCE

applying passion and dedication – taking pride in helping our clients make better decisions in healthcare

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GLOBAL

 

AFRICA HEALTHCARE MARKET PRESENTS UNIQUE CHALLENGES

As a pharmaceutical market, Africa is highly fragmented without the large wholesale channels that exist in North America and Europe. Small pharmacies make up the largest share of the retail market in Africa, while the ten largest retail chains in Nigeria, Kenya and Ghana manage less than 200 locations in total.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THE FUTURE OF INSULIN TRACKING IS BLOOD-FREE

While new and improved diabetes therapies continue to be developed by the pharmaceutical industry, technology companies are also introducing non-invasive glucose monitoring devices which could mean the end of the never-ending “sticks” well-known to diabetic patients.

Non-invasive glucose monitoring is now available from Integrity Applications and others are coming soon.

 

SIMPLE BLOOD TEST FOR CANCER DETECTION

A new early detection tool called the Galleri Test offers the potential for recognizing the early stages of 50 different cancers well before there are any visible symptoms.

While cancer screening is not new, traditional tests only looked for a single type of cancer.  The benefit of this new option is to screen for a wide array of cancers using Next-Generation DNA Sequencing and machine learning.

WHY IS COLORECTAL CANCER RISING IN THE YOUNG?

Colorectal cancer (CRC) is relatively rare but there is an alarming trend of diagnosed cases among those under age 50 worldwide, leaving healthcare professionals and researchers wondering why given that other health trends seem favorable.

For example, the cases of CRC in the United States have increased 51% since 1994 among those under age 50 (according the American Cancer Society).

 

WE ARE AWESTRUCK

at the mystery of being human, while inspired by its potentials

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMMITTED TO THE GOAL OF SUPPORTING HEALTHCARE

Striving for perfection in supporting researchers, developers, manufacturers, suppliers and distributors